Osteoporosis Research Ltd
Manufacture of basic pharmaceutical products
Osteoporosis Research Ltd contacts: address, phone, fax, email, website, shedule
Address: 235 Old Marylebone Road NW1 5QT London
Phone: +44-1530 5767791
Fax: +44-1530 5767791
Email: n\a
Website: n\a
Shedule:
Incorrect data or we want add more details informations for "Osteoporosis Research Ltd"? - send email to us!
Registration data Osteoporosis Research Ltd
Register date: 2012-02-01
Register number: 07932529
Type of company: Private Limited Company
Get full report form global database UK for Osteoporosis Research LtdOwner, director, manager of Osteoporosis Research Ltd
Professor John Anthony Kanis Director. Address: Old Marylebone Road, London, NW1 5QT, United Kingdom. DoB: September 1944, British
Derek Richard Gray Director. Address: Old Marylebone Road, London, NW1 5QT, United Kingdom. DoB: June 1933, British
Patrice Mary Mckenney Director. Address: Old Marylebone Road, London, NW1 5QT, United Kingdom. DoB: March 1960, Irish
Judith Anne Stenmark Director. Address: Old Marylebone Road, London, NW1 5QT, United Kingdom. DoB: May 1958, Australian
Jobs in Osteoporosis Research Ltd vacancies. Career and practice on Osteoporosis Research Ltd. Working and traineeship
Sorry, now on Osteoporosis Research Ltd all vacancies is closed.
Responds for Osteoporosis Research Ltd on FaceBook
Read more comments for Osteoporosis Research Ltd. Leave a respond Osteoporosis Research Ltd in social networks. Osteoporosis Research Ltd on Facebook and Google+, LinkedIn, MySpaceAddress Osteoporosis Research Ltd on google map
Other similar UK companies as Osteoporosis Research Ltd: Harcol Investments Limited | Alderbank Estates Ltd | C D S Properties Limited | Leading Edge Estates Limited | White Orchid Properties Ltd
Registered as 07932529 four years ago, Osteoporosis Research Ltd is categorised as a Private Limited Company. The company's actual mailing address is 235 Old Marylebone Road, London. Osteoporosis Research Ltd was registered three years ago as Iof Research. This firm SIC and NACE codes are 21100 meaning Manufacture of basic pharmaceutical products. The company's latest records were submitted for the period up to 2015-03-31 and the most current annual return information was filed on 2016-02-01. From the moment the company was launched 4 years ago, it became one of the leaders of the market.
In order to satisfy their customer base, this specific firm is being controlled by a body of two directors who are Professor John Anthony Kanis and Derek Richard Gray. Their support has been of critical importance to this firm since February 2012.